76 related articles for article (PubMed ID: 12242545)
21. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
22. Abnormal motor cortex excitability in congenital stroke.
Berweck S; Walther M; Brodbeck V; Wagner N; Koerte I; Henschel V; Juenger H; Staudt M; Mall V
Pediatr Res; 2008 Jan; 63(1):84-8. PubMed ID: 18043504
[TBL] [Abstract][Full Text] [Related]
23. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
24. Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: an effective tool to investigate in vivo GABAergic cortical inhibition in humans.
Pierantozzi M; Marciani MG; Palmieri MG; Brusa L; Galati S; Caramia MD; Bernardi G; Stanzione P
Brain Res; 2004 Nov; 1028(1):1-8. PubMed ID: 15518635
[TBL] [Abstract][Full Text] [Related]
25. Zonisamide decreases cortical excitability in patients with idiopathic generalized epilepsy.
Joo EY; Kim SH; Seo DW; Hong SB
Clin Neurophysiol; 2008 Jun; 119(6):1385-92. PubMed ID: 18396455
[TBL] [Abstract][Full Text] [Related]
26. Long-term and cumulative effects of sports concussion on motor cortex inhibition.
De Beaumont L; Lassonde M; Leclerc S; Théoret H
Neurosurgery; 2007 Aug; 61(2):329-36; discussion 336-7. PubMed ID: 17762745
[TBL] [Abstract][Full Text] [Related]
27. Cortical silent period prolongation in spinocerebellar ataxia type 2 (SCA2).
Restivo DA; Lanza S; Giuffrida S; Le Pira F; Drago MT; Di Mauro R; Palmeri A; Puzzo D; Di Bella P; Sessa E; Rifici C; D'Aleo G; Muscarà N; Bramanti P
Funct Neurol; 2004; 19(1):37-41. PubMed ID: 15212115
[TBL] [Abstract][Full Text] [Related]
28. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation.
Caramia MD; Palmieri MG; Desiato MT; Boffa L; Galizia P; Rossini PM; Centonze D; Bernardi G
Clin Neurophysiol; 2004 Apr; 115(4):956-65. PubMed ID: 15003779
[TBL] [Abstract][Full Text] [Related]
29. A new measure of acute physiological derangement for patients with exacerbations of obstructive airways disease: the COPD and Asthma Physiology Score.
Wildman MJ; Harrison DA; Welch CA; Sanderson C
Respir Med; 2007 Sep; 101(9):1994-2002. PubMed ID: 17616454
[TBL] [Abstract][Full Text] [Related]
30. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Hallin R; Koivisto-Hursti UK; Lindberg E; Janson C
Respir Med; 2006 Mar; 100(3):561-7. PubMed ID: 16019198
[TBL] [Abstract][Full Text] [Related]
31. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease.
Fraix V; Pollak P; Vercueil L; Benabid AL; Mauguière F
Clin Neurophysiol; 2008 Nov; 119(11):2513-8. PubMed ID: 18783985
[TBL] [Abstract][Full Text] [Related]
32. Normal cortical excitability in Myoclonus-Dystonia--a TMS study.
van der Salm SM; van Rootselaar AF; Foncke EM; Koelman JH; Bour LJ; Bhatia KP; Rothwell JC; Tijssen MA
Exp Neurol; 2009 Apr; 216(2):300-5. PubMed ID: 19118553
[TBL] [Abstract][Full Text] [Related]
33. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study.
Ferreri F; Pauri F; Pasqualetti P; Fini R; Dal Forno G; Rossini PM
Ann Neurol; 2003 Jan; 53(1):102-8. PubMed ID: 12509853
[TBL] [Abstract][Full Text] [Related]
34. Cortical inhibition and excitation in abstinent cocaine-dependent patients: a transcranial magnetic stimulation study.
Sundaresan K; Ziemann U; Stanley J; Boutros N
Neuroreport; 2007 Feb; 18(3):289-92. PubMed ID: 17314673
[TBL] [Abstract][Full Text] [Related]
35. Difference in intracortical inhibition of the motor cortex between cortical myoclonus and focal hand dystonia.
Hanajima R; Okabe S; Terao Y; Furubayashi T; Arai N; Inomata-Terada S; Hamada M; Yugeta A; Ugawa Y
Clin Neurophysiol; 2008 Jun; 119(6):1400-7. PubMed ID: 18387338
[TBL] [Abstract][Full Text] [Related]
36. Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease.
Tsoumakidou M; Tzanakis N; Chrysofakis G; Kyriakou D; Siafakas NM
Respir Med; 2005 May; 99(5):572-9. PubMed ID: 15823454
[TBL] [Abstract][Full Text] [Related]
37. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients.
Cantello R; Tarletti R; Varrasi C; Cecchin M; Monaco F
Neuroscience; 2007 Nov; 150(1):64-71. PubMed ID: 17964730
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation.
Tsai CL; Clark S; Cydulka RK; Rowe BH; Camargo CA
Acad Emerg Med; 2007 Jan; 14(1):6-14. PubMed ID: 17119187
[TBL] [Abstract][Full Text] [Related]
39. Abnormal intracortical facilitation in early-stage Huntington's disease.
Nardone R; Lochner P; Marth R; Ausserer H; Bratti A; Tezzon F
Clin Neurophysiol; 2007 May; 118(5):1149-54. PubMed ID: 17336146
[TBL] [Abstract][Full Text] [Related]
40. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
